Mirova Abbott Laboratories Transaction History

Mirova

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $18,218 - $22,300	-202 Reduced 5.75%	3,309 $364,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $590,853 - $708,924	-6,185 Reduced 63.79%	3,511 $340,000
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $1.07 Million - $1.2 Million	-10,666 Reduced 52.38%	9,696 $1.06 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $108,580 - $127,805	-1,121 Reduced 5.22%	20,362 $2.06 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $530,339 - $622,170	5,579 Added 35.08%	21,483 $2.36 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.54 Million - $1.78 Million	15,904 New	15,904 $1.54 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $872,482 - $1.07 Million	-7,552 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $79,095 - $87,502	678 Added 9.86%	7,552 $892,000
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $8,357 - $9,837	-79 Reduced 1.14%	6,874 $796,000
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $133,764 - $157,594	1,229 Added 21.47%	6,953 $833,000
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $493,395 - $537,659	4,699 Added 458.44%	5,724 $626,000
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $93,931 - $114,072	1,025 New	1,025 $112,000
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $228,405 - $266,390	-3,134 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $61,849 - $74,776	934 Added 42.45%	3,134 $251,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $144,232 - $163,394	2,200 New	2,200 $159,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

Stay updated on Mirova with notifications on news.